Sanofi (SNY) Net Income towards Common Stockholders (2009 - 2026)

Sanofi (SNY) has 18 years of Net Income towards Common Stockholders data on file, last reported at $1.57 in Q1 2026.

• Quarterly Net Income towards Common Stockholders fell 1.88% year-over-year to $1.57 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.89 (up 113.79% YoY) and the FY2025 annual result came in at $7.45, up 57.02% from the prior year.
• Net Income towards Common Stockholders slipped to $1.57 in Q1 2026 per SNY's latest filing, from $7.45 in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $3.2 billion in Q4 2022, with the low at $0.96 in Q2 2024.
• Average Net Income towards Common Stockholders over 5 years is $895.8 million, with a median of $7.45 recorded in 2025.
• Year-over-year, Net Income towards Common Stockholders surged 1541409358387.04% in 2022 and plunged 100.0% in 2024.
• Sanofi's Net Income towards Common Stockholders stood at $3.2 billion in 2022, then tumbled by 100.0% to $4.64 in 2023, then grew by 2.31% to $4.74 in 2024, then surged by 57.02% to $7.45 in 2025, then slumped by 78.94% to $1.57 in 2026.
• Business Quant data shows SNY's Net Income towards Common Stockholders at $1.57 in Q1 2026, $7.45 in Q4 2025, and $8.23 in Q3 2025.